EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Serum LINC00861: A novel biomarker for diabetic nephropathy diagnosis and a promoter of renal injury via miR-378a-3p

Haihui Li, Mengmeng Pu, Hong Xia, Dongcai Feng iD, Qiong Xiao

Diabetes & Vascular Disease Research · 2026-03 · 23 (2)

DOI: 10.1177/14791641261431771 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes & Vascular Disease Research, online erschienen am 15.04.2026. Verfasst von Haihui Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Beijing Chao-yang Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Diabetic Nephropathies, MicroRNAs, RNA, Long Noncoding, Diabetes Mellitus, Type 2. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This study investigated the expression and diagnostic significance of LINC00861 in DN and explored its functional mechanisms in high glucose-induced cell damage.

Methods

We enrolled 285 participants: 92 healthy controls, 98 uncomplicated T2DM patients, and 95 DN patients. Serum LINC00861 and miR-378a-3p levels were measured via qRT-PCR. Correlations with clinical parameters were assessed using Pearson analysis. Logistic regression identified risk factors for DN progression, and ROC curves evaluated diagnostic accuracy. In vitro, LINC00861 was knocked down to assess its effects on proliferation, inflammation, and oxidative stress under high glucose. Targeting of miR-378a-3p was confirmed by dual-luciferase and RIP assays.

Results

The LINC00861 expression was significantly elevated in DN patients compared to T2DM and healthy controls, and correlated positively with FBG, HbA1c, and albuminuria, but negatively with eGFR. Multivariate analysis identified LINC00861 as an independent risk factor for DN. The AUC for distinguishing T2DM from DN was 0.918. miR-378a-3p expression was significantly lower in DN patients than in those with T2DM or healthy controls. LINC00861 silencing may alleviate HG induced aberrant proliferation, inflammatory responses, and oxidative stress, possibly via the regulation of miR-378a-3p.

Conclusion

The LINC00861 is upregulated in DN and may facilitate renal injury by sponging miR-378a-3p, indicating its potential as a diagnostic biomarker and therapeutic target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic NephropathiesMicroRNAsRNA, Long NoncodingDiabetes Mellitus, Type 2HumansFemaleCase-Control StudiesMaleOxidative StressMiddle AgedBiomarkersPredictive Value of TestsRisk FactorsCell ProliferationAged

Stichwörter der Autor:innen

HMCsLINC00861biomarkerdiabetic nephropathydiagnosis

Substanzen

MicroRNAsMIRN378 microRNA, humanRNA, Long NoncodingBiomarkers

Autor:innen und Institutionen

  • Department of Endocrinology, Beijing Chao-yang Hospital, Capital Medical University, Beijing, China.
  • Department of Nephrology, Xingtai People's Hospital, Xingtai, Hebei, China.
  • Nephrology Department, Shanghai Putuo District People's Hospital, Shanghai, China.
  • Cardiology Department, The Third Xiangya Hospital of Central South University, Changsha, China.
  • Blood Purification Department, Central Theater Command General Hospital, Wuhan, China.

ORCID-Profile: Dongcai Feng

Zitieren

APA

Li, H., Pu, M., Xia, H., Feng, D., & Xiao, Q. (2026). Serum LINC00861: A novel biomarker for diabetic nephropathy diagnosis and a promoter of renal injury via miR-378a-3p. Diabetes & Vascular Disease Research, 23(2). https://doi.org/10.1177/14791641261431771

Vancouver

Li H, Pu M, Xia H, Feng D, Xiao Q. Serum LINC00861: A novel biomarker for diabetic nephropathy diagnosis and a promoter of renal injury via miR-378a-3p. Diabetes & Vascular Disease Research. 2026;23(2). doi:10.1177/14791641261431771

BibTeX
@article{Li2026,
  author = {Li, Haihui and Pu, Mengmeng and Xia, Hong and Feng, Dongcai and Xiao, Qiong},
  title = {Serum LINC00861: A novel biomarker for diabetic nephropathy diagnosis and a promoter of renal injury via miR-378a-3p},
  journal = {Diabetes & Vascular Disease Research},
  year = {2026},
  volume = {23},
  number = {2},
  doi = {10.1177/14791641261431771}
}
Kostenlos starten →